Emergent BioSolutions Inc. (NYSE: EBS) announced today that it
will present at the Acumen BioFin Rodman and Renshaw 4th Annual Global
Healthcare Conference on May 15, 2007 at 12:15 pm Central European
Time (6:15 am Eastern Time) at the Le Meridien Beach Plaza Hotel,
Monte Carlo, Monaco. Company management will provide a corporate
overview including an update of the company's product development
programs and recent corporate activities.
A webcast of the presentation will be available both live and by
replay. To access both the live and archived webcast, please go to
www.emergentbiosolutions.com, click on the "Investors" link and
proceed to the "Webcasts & Presentations" section. The archived replay
will be available 24 hours after the live presentation and will be
accessible for 30 days.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a biopharmaceutical company
dedicated to one simple mission--to protect life. We develop,
manufacture and commercialize immunobiotics, consisting of vaccines
and therapeutics that assist the body's immune system to prevent or
treat disease. Our biodefense business focuses on immunobiotics for
use against biological agents that are potential weapons of
bioterrorism and biowarfare. Our marketed product, BioThrax(R)
(Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S.
Food and Drug Administration for the prevention of anthrax infection.
Our commercial business focuses on immunobiotics for use against
infectious diseases and other medical conditions that have resulted in
significant unmet or underserved public health needs. More information
on the company is available at www.emergentbiosolutions.com.
